Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Learn the long-term average annual return for index funds and how it informs portfolio construction, diversification, and risk management.
27,739 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
A JPMorgan forecast suggests the S&P 500 could rise about 22% from current levels to roughly 9,000 by mid-2027, led b...
A veteran fund manager who compiles a 40%-a-year track record remains bullish on semiconductors, arguing the next wav...
New housing designs like duplexes and townhomes are rising in policy talks, but recent data show they don’t automatic...
A public clash between a legendary director and a veteran actor isn’t just drama. It’s a window into how money, reput...
A long-stalled crypto bill in Congress shows little traction after Trump’s social media post. TD Cowen notes that pre...
European ministers press Washington for clear goals as talks on a naval coalition to secure Gulf shipping falter, rai...
A sharp slide in South Korea's equities market sparks a broader risk-off wave, with Bitcoin and other crypto assets w...
REX Shares launches a new wave of ETF products focused on income, leverage, crypto, and thematic strategies to meet d...
SM Energy surged 37% year-to-date after finalizing its Civitas Resources merger, but a quarterly miss underscored lev...
In a speculative timeline, Kevin Warsh is named Federal Reserve Chair, prompting a rethink of policy amid AI-driven g...
The Nasdaq Composite nudged lower as oil prices climbed and inflation remained above the Fed's target, signaling a ca...